✦ LIBER ✦

Application of neoadjuvant chemoendocrine therapy for operable breast carcinomas

✍ Scribed by ANDREAS MAKRIS

Book ID: 108710125
Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 529 KB
Volume: 6
Category: Article
ISSN: 0961-5423
DOI: 10.1111/j.1365-2354.1997.tb00320.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction in angiogenesis after neoadjuv

Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma

✍ Andreas Makris; Trevor J. Powles; Stelios Kakolyris; Mitch Dowsett; Sue E. Ashle 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

## BACKGROUND. The intensity of angiogenesis, as measured by microvessel density, is a strong independent predictor of survival in breast carcinoma patients. The impact of chemotherapy and/or endocrine therapy on this process is unknown. ## METHODS. Histologic samples from patients randomized t

Neoadjuvant Versus Adjuvant Systemic The

Neoadjuvant Versus Adjuvant Systemic Therapy for Operable Breast Cancer

✍ Smith, Barbara L. 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 737 KB

52 Rates of local recurrence with neoadj

52 Rates of local recurrence with neoadjuvant chemoendocrine therapy for primary breast cancer

✍ J.R. Benson; T.J. Powles; A. Makris; G. Knee; S. Ashley; A.G. Nash 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

U.S. Experience in Neoadjuvant Therapy o

U.S. Experience in Neoadjuvant Therapy of Operable Breast Cancer

✍ Buzdar, Aman U.; Hortobagyi, Gabriel N. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Neoadjuvant Chemotherapy for Operable Br

Neoadjuvant Chemotherapy for Operable Breast Cancer: Individualizing Locoregional and Systemic Therapy

✍ Bear, Harry D. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 644 KB

A randomized trial of adjuvant endocrine

A randomized trial of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer stratified by estrogen receptors

✍ Yasuo Nomura; Hideya Tashiro; Kazufumi Hisamatsu; Katsuko Shinozuka 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

Based on estrogen receptor (ER) status and menopausal status, operable breast cancer (International Union Against Cancer [UICC] Stage I, II, and III) patients were randomized for adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy, and the effects on the disease-free survival (DFS)